Monoclonal Antibody of 100 μg targeting ORC2 for ICC, IPP, WB.
| Product Specifications | |
| Application | ICC, IP, WB |
| Reactivity | Human |
| Clonality | Monoclonal IgG1 ĸ |
| Host | Mouse |
| Immunogen | Recombinant human ORC2 (1-577aa.) |
| Gene ID - Human | |
| Gene ID - Mouse | |
| Formulation | 100 μg IgG in 100 μl volume of PBS containing 50% glycerol, pH 7.2. No preservative iscontained. |
| Citations for Anti-ORC2 (Human) mAb (Clone: 3B7) – 3 Found |
| Hsieh, Kan-Yen; Wei, Chien-Kei; Wu, Chin-Chung. YC-1 Prevents Tumor-Associated Tissue Factor Expression and Procoagulant Activity in Hypoxic Conditions by Inhibiting p38/NF-κB Signaling Pathway. International Journal Of Molecular Sciences. 2019;20(2) PubMed - Comments: Used in: WB |
| De Leo, Alessandra; Deng, Zhong; Vladimirova, Olga; Chen, Horng-Shen; Dheekollu, Jayaraju; Calderon, Abram; Myers, Kenneth A; Hayden, James; Keeney, Frederick; Kaufer, Benedikt B; Yuan, Yan; Robertson, Erle; Lieberman, Paul M. LANA oligomeric architecture is essential for KSHV nuclear body formation and viral genome maintenance during latency. Plos Pathogens. 2019;15(1):e1007489. PubMed - Comments: Used in: ICC |
| De Leo, Alessandra; Deng, Zhong; Vladimirova, Olga; Chen, Horng-Shen; Dheekollu, Jayaraju; Calderon, Abram; Myers, Kenneth A; Hayden, James; Keeney, Frederick; Kaufer, Benedikt B; Yuan, Yan; Robertson, Erle; Lieberman, Paul M. LANA oligomeric architecture is essential for KSHV nuclear body formation and viral genome maintenance during latency. Plos Pathogens. 2019;15(1):e1007489. PubMed - Comments: Used in: ChIP |
